Bridging the gap: Human diploid cell strains and the origin of AIDS

Journal of Theoretical Biology

Volumn 204, Issue 4, 2000, Pages 497-503

  Goldberg, Billi ^a   Stricker, Raphael B ^b  

^a Dinitrochlorobenzene Study Group   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; POLIOMYELITIS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CHIMPANZEE; DIPLOIDY; EPIDEMIC; GENETIC MANIPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; VIRUS MUTATION; VIRUS TYPING;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PAN TROGLODYTES; UNIDENTIFIED RETROVIRUS;

EID: 0034697621     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.2033     Document Type: Article

References (67)

1. Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde
2. Viral RNA-dependent DNA polymerase
3. Possibilities of vaccine manufacture in human diploid cell strains with a serum replacement factor
4. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
5. Acquired immunodeficiency syndrome in African patients
6. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi
7. The origin of AIDS
8. Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains
9. Polio vaccines and the origin of AIDS
10. Polio vaccines and the origin of AIDS
11. Simian immunodeficiency virus in people
12. The origin of the AIDS virus
13. Infection of primary human placental fibroblasts with HIV-1, HIV-2, and SIV
14. Isolation of foamy virus from rhesus, African green and cynomolgus monkey leukocytes
15. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men
16. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
17. Origin of AIDS
18. Comments
19. A comparison of primary monkey kidney, heteroploid cell lines, and human diploid cell strains for human virus vaccine preparation
20. Advances in tissue culture methods important to viral disease problems
21. The cell biology of aging
22. Origin of HIV-1
23. A novel technique for transforming the theft of mortal human cells into praiseworthy federal policy
24. The serial cultivation of human diploid cell strains
25. Preparation of poliovirus vaccines in a human fetal diploid cell strain
26. Sequence analysis of HIV-1 Group O from Norwegian patients infected in the 1960s
27. The gay bowel syndrome: Clinicopathologic correlation in 260 cases
28. Analysis of live, oral poliovirus vaccine monopools for human immunodeficiency virus type 1 and simian immunodeficiency virus
29. Polio vaccines and retroviral contamination
30. Simian retroviruses, poliovaccine, and origin of AIDS
31. Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine
32. Establishing specific retrovirus-free breeding colonies of macaques: An approach to primary screening and surveillance
33. What immunity can protect against HIV infection?
34. Sabin polio vaccine for herpes simplex
35. Foamy viruses are unconventional retroviruses
36. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations
37. Infection of human fibroblasts and osteoblast-like cells with HIV-1
38. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease
39. Infection of human gastrointestinal cells by HIV-1
40. Tenth anniversary perspectives on AIDS. HIV: Between past and future
41. Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959
42. Foamy viruses
43. Acquired immunodeficiency syndrome in a heterosexual population in Zaire
44. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo: 3. Safety and efficacy during the first 21 months of study
45. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
46. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection
47. Human exposure to SV40: Review and comment
48. Infection of gastrointestinal tract macrophages by HIV-1
49. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus
50. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy
51. Safety of the hepatitis B vaccine
52. Polio vaccines and retroviral contamination
53. Large-scale efficacy trials of hepatitis B vaccines in the USA: Baseline data and protocols
54. Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
55. The immune response of healthy adults to a reduced dose of hepatitis B vaccine
56. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report
57. Hepatitis B vaccine in medical staff of hemodialysis units: Efficacy and subtype cross-protection
58. Preliminary report on the treatment of recurrent herpes simplex with poliomyelitis vaccine (Sabin's)
59. RNA-dependent DNA polymerase in virions of Rous sarcoma virus
60. Acquired immunodeficiency syndrome in Rwanda
61. FDA weighs using tumor cell lines for vaccine development
62. Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm
63. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic